Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Biota Holdings Ltd.       AU000000BTA1

BIOTA HOLDINGS LTD.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Australia's Biota, Nabi Pharmaceuticals Plan Merger

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/23/2012 | 05:31am CEST

("Australia's Biota, Nabi Pharmaceuticals Plan Merger," at 2313 GMT, misstated the return to shareholders in the final paragraph. The correct version follows:)

Australian drug development company Biota Holdings Ltd. (>> Biota Holdings Ltd.) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq.

Biota said in a statement the move to the U.S. was designed to achieve better value recognition and liquidity through a stronger U.S. shareholder base.

"We believe this is a necessary step to increase our options for the development and commercialization of our product portfolio and will ultimately improve the recognition of the underlying value of our product portfolio for our shareholders," said Biota Chairman Jim Fox.

Biota develops anti influenza drugs such as Relenza, which is marketed by GlaxoSmithKline PLC.

Under the merger, Nabi will acquire all the shares in Biota for new shares in the name of Biota Pharmaceuticals, a Nasdaq listed company. Biota shareholders will own about 74% of Biota Pharmaceuticals and Nabi shareholders will own about 26% of the company.

Under the proposed merger Nabi will bring US$54 million to the new company, and excess cash, estimated to be around US$30 million, would be returned to existing Nabi shareholders.

-By Gavin Lower, Dow Jones Newswires; 61-3-9292-2095; [email protected]

Stocks mentioned in the article : Biota Holdings Ltd.
Stocks mentioned in the article
ChangeLast1st jan.
BIOTA PHARMACEUTICALS INC --End-of-day quote.
GLAXOSMITHKLINE 0.39% 1500 Delayed Quote.12.98%
GLAXOSMITHKLINE -0.60% 16.99 Delayed Quote.13.94%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOTA HOLDINGS LTD.
2012U.S. HOT STOCK FUTURES : Hot stocks to watch
DJ
2012U.S. HOT STOCK FUTURES : Hot stocks to watch
DJ
2012Nabi, Biota Consider Former Inhibitex Executive Plumb as New CEO
DJ
2012Nabi Biopharmaceuticals to Buy Back $23 Million of Stock in Self-Tender Offer
DJ
2012BIOTA HOLDINGS LTD. : Appendix 3B: New issue announcement
PU
2012Australia's Biota, Nabi Pharmaceuticals Plan Merger
DJ
2012Australia's Biota, Nabi Pharmaceuticals Plan Merger
DJ
2011BIOTA HOLDINGS LTD. : Notice of Annual General Meeting 2011-Example Proxy Form
PU
2011BIOTA HOLDINGS LTD. : Biota Announces Royalties from Inavir® and Relenza? for Q4..
BU
More news
Income Statement Evolution
Managers
NameTitle
Ian David Gust Independent Non-Executive Director
Paul Ronald Bell Independent Non-Executive Director
Raafat E. F. Fahim Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOTA HOLDINGS LTD.121
CELLTRION, INC.--.--%32 036
IQVIA HOLDINGS INC4.64%20 818
LONZA GROUP1.63%20 226
INCYTE CORPORATION-29.71%14 505
NEKTAR THERAPEUTICS42.83%13 705